목시계 형태의 혈압 측정기 휴이노 소개

1. Yeongjoon Gil, Ph.D.
Founder & CEO
INNOVATION for HUMAN

2. We are working to disrupt the healthcare industry
through wearable technology .
CICLO by HUiNNO is a smart-watch that can
instantaneously detect blood pressure, heart rate, ECG,
and more for the health-conscious early adaptors and
people with blood pressure problems.

3. WHAT IS ONE OF THE MOST
IMPORTANT VITAL SIGN?

4. BLOOD PRESSURE

5. Hypertension (High BP) is a leading cause of stroke, heart attack, de
mentia, kidney failure, etc.
PROBLEM
406,351
deaths
(2007)
1
in every
1.3
minute

6. If you can continuously be aware of
Blood Pressure to manage and
control hypertension,
you can significantly reduce risk of
life-threatening complications
[1] Jeffrey J. Goldberger, Michael E. Cain, Stefan H. Hohnloser, Alan H. Kadish, Bradley P. Knight, Michael S. Lauer, Barry J. Maron, Richard L.
Page, Rod S. Passman, David Siscovick, William G. Stevenson, Douglas P. Zipes, “American Heart Association/American College of Cardiology
Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden
Cardiac Death”, Circulation 2008, pp. 1497-1518, 2009.

7. PROBLEM
Existing monitors cannot measure blood
pressure continuously and conveniently
This is a big problem for hypertension patients

8. BP Monitors are very difficult and inconvenient to use
PROBLEM
All current devices are
• PRESSURE & CUFF BASED
• VERY SLOW
• CAN’T USE CONTINUOUSLY
• UNCOMFORTABLE
• INACCURATE

9. Wearable devices can’t measure Blood Pressure
PROBLEM
All of the wearable devices are focusing more on healthcare,
but no device can measure the most vital sign:
BLOOD PRESSURE

10. Wearables Are Totally Failing
Wired News
As of September 30, there were 266
wearable devices on the market [1]
[1] http://www.wired.com/2014/11/where-fitness-trackers-fail/

11. Wearables Are Totally Failing
Wired News
Wearable medical devices are currently a $2.8b market and will
grow 25% p.a. by 2019 to $8.3b[1].
[1] http://www.wired.com/2014/11/where-fitness-trackers-fail/
$2.8 B
2014
$8.3 B
2019

12. SOLUTION

13. CICLO by HUiNNO

14. INSTANT BLOOD PRESSURE
HIGHLY ACCURATE
CONVENIENT
1-seconds to measure BP
Provide up to 94% accuracy via
combining biometrics (ECG + PTT + SpO2 )
No cuffs or pressures to measure
continuous and accurate BP
CICLO by HUiNNO

15. No-Delay Blood Pressure Measurement Algorithm
(Patent in KR: 10-2014-0068122)
1 Second
to measure your BP every time

16. 50 subject clinic trial at Pusan National University hospital
Provide BP measurement up to
94% Accuracy
via combining biometrics ( ECG + PTT + SpO2 )
95%+ accuracy receives
Grade A
from BHS (British Hypertension Society)

17. 42%
70%
86%
68%
84%
94%
≤5mmHg ≤10mmHg ≤15mmHg
PTT PTT(t),SpO2(t),ECG(t)
Blood Pressure Calculation Algorithm
(Patent in KR: 10-2013-0116158)
Highly accurate ( 94% )

18. Convenient (Cuff-less)
Wearable Style UX
(Patent in KR: 10-2013-0116165)

19. HUiNNO vs Other BP Monitors
1) ECG - Electrocardiogram
2) SpO2 - Saturation of peripheral Oxygen
Developer Parameter Accurate Instant Continuous
Biofeedback
Platform
Visi Mobile Oscillation
Withings Oscillation
Bpro PPG
Samsung
Electronics
PTT
MIT
Prototype
PTT
OUR
DEVICE
ECG1)
+ PTT + SpO2
2)

20. MARKET

21. $1.2
Billion
in 2015
55 Million
Users in 2015
1 out of 3
suffer from hypertension
Blood Pressure monitoring
market is projected to grow
to 1.2 Billion USD in 2015
(HIS Media Group 2013)
Smart Watch users to grow to
55 Million in 2015
(Business Insider 2014)
32.5% of adults in the U.S.
over 20 suffer from
hypertension
(M brain trend monitor 2014.02)
Blood Pressure Monitor + Smart Watch Market
MARKET
Increase in demand for blood pressure measurement in smart devices

22. DEVICE APP / SERVICE CLOUD PLATFORM
165
80
CUSTOMERS HEALTHCARE
Business Model

23. Business Development
Samsung
Hyundai
LG
LINA
OSCAR
In NYC
PNUH
NDA by Samsung Electronics
(Open Innovation Center in Palo-alto)
Strategy investor partnership Review
(Hyundai Motors Venture Investment Team)
KT
Licensing Review
(Future Convergence IT with Biometrics)
Proposed a New Product
(For hypertension patients)
Pilot Project with Korea gov.
(Tele-medicine or Tele-monitoring)
Partnership Review
(Alternative for Misfit)
Strategically Partnership Review
(About 500ea Ordering Review)

24. June.2014
Incorporation in US
Dec.2014
Working Mock-up
July.2014
Incorporation in KR
Q1.2015
Clinic trial
Q2.2015
FDA approved
Q4.2015
Launching
Q3.2015
Mass product
Milestone

25. HUiNNO. Inc.
www.huinno.com
E-mail: kyzoon@huinno.com
INNOVATION for HUMAN